Actively Recruiting
Multiparametric MRI for Characterization of Hepatocellular Carcinoma
Led by University Hospital Muenster · Updated on 2025-07-02
128
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective observational study investigates using multiparametric magnetic resonance imaging (MRI) to improve the characterization and management of therapy for hepatocellular carcinoma (HCC). The goal is to evaluate whether advanced MRI parameters can support noninvasive diagnostic assessments and personalized treatment plans for patients with HCC. The study is being conducted at a single university center in Germany and includes adult patients with confirmed or suspected HCC. Participants will undergo standardized multiparametric MRI examinations, and the imaging data will be correlated with clinical, pathological, and therapeutic outcomes. No study-specific interventions or medications will be administered.
CONDITIONS
Official Title
Multiparametric MRI for Characterization of Hepatocellular Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Confirmed or suspected diagnosis of hepatocellular carcinoma (HCC)
- Scheduled to receive transarterial chemoembolization (TACE) or selective internal radiotherapy (SIRT) as part of standard clinical care
- Eligible for liver MRI
- Willing and able to provide written informed consent
You will not qualify if you...
- Contraindications to MRI such as pacemakers, ferromagnetic implants, or severe claustrophobia
- Known allergy or intolerance to gadolinium-based contrast agents
- Renal insufficiency with estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73m�b2
- Pregnancy or breastfeeding
- Inability to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinic of Radiology, University of Münster
Münster, Germany
Actively Recruiting
Research Team
M
Max Masthoff, MD
CONTACT
P
Philipp Schindler, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here